AZT — Arcticzymes Technologies ASA Share News
0.000.00%
Last trade - 00:00- NOK1.02bn
- NOK776.49m
- NOK112.62m
Brief: Biotec Pharmacon: Woulgan Listing on UK Dug Tariff One Month Earlier
Brief: Biotec Pharmacon says Woulgan will be listed on UK Drug Tariff
Brief: Biotec Pharmacon Q3 EBITDA loss widens to NOK 7.3 mln
Brief: Biotec Pharmacon subsidiary expands into bio-manufacturing market
Brief: Biotec enters into supply agreement for M-Glucan to pet sector
Brief: Biotec Pharmacon appoints Christian Jørgensen new CEO
Brief: Biotec's Woulgan application to be reconsidered by UK Drug Tariff
Brief: Biotec prolongs supply agreement for delivery of M-Glucan
Brief: Biotec Pharmacon enters into supply agreement for M-Gard in USA
Brief: Biotec Pharmacon Q2 EBITDA loss widens to NOK 4.4 mln
Brief: Oslo Bourse takes Grieg, Spb 1 SR Bank, Gaming Innovation and Link Mobility into osebx share index
Brief: Biotec Pharmacon pantent granted in the US
Brief: UK Drug Tariff rejects current Woulgan application
Brief: Biotec Pharmacon Q1 EBITDA loss widens to NOK 4.1 mln
Brief: Biotec Pharmacon's CEO Svein W. F. Lien resigns due to health issues
Brief: Biotec Pharmacon Q4 EBITDA loss widens to NOK 8.1 mln
Brief: Biotec Pharmacon EBITDA loss widens to NOK 5.9 million
Brief: Biotec Pharmacon signs supply agreement in Germany
Brief: Biotec Pharmacon: Arcticzymes launches polymerase product, gets patent in US